CrAg lateral flow assay for cryptococcosis

Bibliography

• Perfect JR. Cryptococcus neoformans. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 7th edition. Churchill Livingstone Elsever; Philadelphia, PA: 2010. p. 3287-303
   Google Scholar
• French N, Gray K, Watera C, Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS 2002;16:1031-8
   PubMed Web of Science ®Google Scholar
• Okongo M, Morgan D, Mayanja B, Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda. Int J Epidemiol 1998;27:698-702
   PubMed Web of Science ®Google Scholar
• Churchyard GJ, Kleinschmidt I, Corbett EL, Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis. Int J Tuberc Lung Dis 2000;4:705-12
   PubMed Web of Science ®Google Scholar
• Park BJ, Wannemuehler KA, Marston BJ, Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009;23:525-30
   PubMed Web of Science ®Google Scholar
• Bicanic T, Meintjes G, Wood R, Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis 2007;45:76-80
   PubMed Web of Science ®Google Scholar
• Kambugu A, Meya DB, Rhein J, Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis 2008;46:1694-701
   PubMed Web of Science ®Google Scholar
• Lessells RJ, Mutevedzi PC, Heller T, Newell ML. Poor long-term outcomes for cryptococcal meningitis in rural South Africa. S Afr Med J 2011;101:251-2
   PubMed Web of Science ®Google Scholar
• WHO Cryptococcal Guideline Working Group. Rapid advice: Diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children. WHO Press, World Health Organization 2011. Available from: http://whqlibdoc.who.int/publications/2011-9789241502979_eng.pdf
   Google Scholar
• Lindsley MD, Mekha N, Baggett HC, Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clin Infect Dis 2011;53:321-5
   PubMed Web of Science ®Google Scholar
• UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases. Sexually Transmitted Diseases Diagnostic Initiative (SDI). World Health Organization 2009. Available from: www.who.int/std_diagnostics
   Google Scholar
• Girosi F, Olmsted SS, Keeler E, Developing and interpreting models to improve diagnostics in developing countries. Nature 2006;444(Suppl 1):3-8
   PubMedGoogle Scholar
• Litvintseva AP, Xu J, Mitchell TG. Population structure and ecology of Cryptococcus neoformans and Cryptococcus gattii. In: Heitman J, Kozel TR, Kwon-Chung KJ, Perfect JR, Casadevall A, editors. Cryptococcus: from Human Pathogen to Model Yeast. ASM Press; Washington, DC: 2011. p. 97-111
   Google Scholar
• Dromer F, Mathoulin S, Dupont B, Individual and environmental factors associated with infection due to Cryptococcus neoformans serotype D. French Cryptococcosis Study Group. Clin Infect Dis 1996;23:91-6
   PubMed Web of Science ®Google Scholar
• Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984;120:123-30
   PubMed Web of Science ®Google Scholar
• Karstaedt AS, Crewe-Brown HH, Dromer F. Cryptococcal meningitis caused by Cryptococcus neoformans var. gattii, serotype C, in AIDS patients in Soweto, South Africa. Med Mycol 2002;40:7-11
   PubMed Web of Science ®Google Scholar
• Litvintseva AP, Thakur R, Reller LB, Mitchell TG. Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in Sub-Saharan Africa. J Infect Dis 2005;192:888-92
   PubMed Web of Science ®Google Scholar
• Thakur R, Steele KT, Nthobatsang R, Prevalence of C. neoformans and C. gattii among patients with cryptococcal meningitis at a tertiary hospital in Gaborone, Botswana: March 2005-February 2007, [abstract 1048]. Abst 47th Annual Meeting IDSA; Philadelphia, PA; 2009
   Google Scholar
• Vanselow M, Brandt ME, Park BJ. Diagnosis and management of cryptococcal disease in resource-limited settings. Curr Fungal Infect Rep 2012;6:35-40
   Google Scholar
• Gordon MA, Vedder DK. Serologic tests in diagnosis and prognosis of cryptococcosis. Am Med Assoc 1966;197:961-7
   PubMed Web of Science ®Google Scholar
• Gade W, Hinnefeld SW, Babcock LS, Comparison of the PREMIER cryptococcal antigen enzyme immunoassay and the latex agglutination assay for detection of cryptococcal antigens. J Clin Microbiol 1991;29:1616-19
   PubMed Web of Science ®Google Scholar
• Jarvis JN, Percival A, Bauman S, Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis 2011;53:1019-23
   PubMed Web of Science ®Google Scholar
• Micol R, Lortholary O, Sar B, Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. J Acquir Immune Defic Syndr 2007;45:555-9
   PubMed Web of Science ®Google Scholar
• Jarvis JN, Lawn SD, Vogt M, Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. Clin Infect Dis 2009;48:856-62
   PubMed Web of Science ®Google Scholar
• Meya DB, Manabe YC, Castelnuovo B, Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < 100 cells/ml who start HIV therapy in resource-limited settings. Clin Infect Dis 2010;51:448-55
   PubMed Web of Science ®Google Scholar
• Micol R, Tajahmady A, Lortholary O, Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia. PLoS One 2010;5:e13856
   PubMed Web of Science ®Google Scholar
• Kozel TR, Thorkildson P, Percival A. Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigen. Clin Vaccine Immunol 2011;18:1292-6
   PubMed Web of Science ®Google Scholar
• Kozel T, Bauman S. New developments in diagnosis: toward a point of care test. Presented at: 8th International Conference on Cryptococus and Cryptococcosis; Charleston, SC; 2011
   Google Scholar
• Yoo SD, Worodria W, Med M, The prevalence and clinical course of HIV-associated pulmonary cryptococcosis in Uganda. J Acquir Immune Defic Syndr 2010;54:269-74
   PubMed Web of Science ®Google Scholar
• Jarvis JN, Wainwright H, Harrison TS, Pulmonary cryptococcosis misdiagnosed as smear-negative pulmonary tuberculosis with fatal consequences. Int J Infect Dis 2010;14S:e310-12
   Google Scholar
• Brizendine KD, Baddley JW, Pappas PG. Pulmonary cryptococcosis. Semin Respir Crit Care Med 2011;32:727-34
   PubMed Web of Science ®Google Scholar
• Driver JA, Saunders CA, Heinze-Lacey B, Sugar AM. Cryptococcal pneumonia in AIDS: is cryptococcal meningitis preceded by clinically recognizable pneumonia? J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:168-71
   PubMedGoogle Scholar
• Harris JR, Lindsley MD, Henchaichon S, High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand. Clin Infect Dis 2012;54:e43-50
   PubMed Web of Science ®Google Scholar
• Rolfes M, Butler E, von Hohenberg M, Paper #953 - Evaluation of a novel point-of-care lateral flow assay to detect cryptococcal antigen in plasma and CSF. 19th Conference on Retroviruses and Opportunistic Infections (CROI) 2012; Available from: http://www.retroconference.org/2012b/Abstracts/44439.htm
   Google Scholar
• Centers for Disease Control and Prevention. Fighting a deadly fungus: A new strategy to reduce deaths due to Cryptococcus. National Center for Emerging & Zoonotic Infectious Diseases 2011. Available from: http://www.cdc.gov/ncezid/dfwed/factsheets/factsheet_cryptococcus_revised%205-17-2011.pdf
   Google Scholar
• WHO. Revised Global Burden of Disease (GBD) 2002 estimates. WHO Health Statistics and Health Information Systems 2002. Available from: http://www.who.int/healthinfo/global_burden_disease/estimates_regional_2002_revised/en/
   Google Scholar